Advanced Enzyme Technologies Ltd Share Price & Stock Analysis

Advanced Enzyme Technologies Ltd (NSE: ADVENZYMES, BSE: 540025) is a Thane, Maharashtra-based company in the Enzymes and Industrial Biotechnology industry. With a market capitalisation of ₹3,151 Cr, it ranks #1,035 by market cap among the 6,197 Indian listed companies on FinBizNet. At ₹284.60 (as of 16 Nov 2026), the share price is 32.1% below its 52-week high of ₹419.00 and 15.3% above its 52-week low of ₹246.80. The share price is down 8.6% over one year and down 5.7% over three months.

Key Metrics

Current Price₹284.60
Market Cap₹3,151 Cr
NSE SymbolADVENZYMES
BSE Code540025
SectorMaterials > Chemicals > Speciality Chemicals
Sub-IndustrySpecialty Chemicals > Enzymes and Industrial Biotechnology
P/E Ratio18.9
Return on Equity11.02%
Return on Assets6.85%
52-Week Range₹246.80 – ₹419.00
1-Year Price Change-8.6%
3-Month Price Change-5.7%
Beta (1Y)0.32
Dividend Yield0.95%
HeadquartersThane, Maharashtra
Websitewww.advancedenzymes.com

Latest Quarterly Results — Q2 FY27

Revenue₹215 Cr
Net Profit₹51 Cr
Net Margin23.8%
EPS (Basic)₹4.33
Basisconsolidated

Figures in ₹ crore, parsed from the company's exchange filing (XBRL).

Advanced Enzyme Technologies Ltd Quarterly Revenue and Profit Trend

Advanced Enzyme Technologies Ltd reported revenue of ₹215 Cr in Q2 FY27, up 16.2% from ₹185 Cr in Q2 FY26 and up 13.0% from ₹190 Cr in Q1 FY27. It posted a net profit of ₹51 Cr for the quarter, against a net profit of ₹45 Cr in Q2 FY26 (up 14.4%). Across the 7 quarters from Q4 FY25 to Q2 FY27, quarterly revenue ranged from ₹167 Cr (Q4 FY25) to ₹215 Cr (Q2 FY27). The company was profitable in each of these 7 quarters.

QuarterRevenueNet ProfitNet Margin
Q2 FY27₹215 Cr₹51 Cr23.8%
Q1 FY27₹190 Cr₹39 Cr20.3%
Q4 FY26₹203 Cr₹45 Cr22.3%
Q3 FY26₹172 Cr₹43 Cr25.1%
Q2 FY26₹185 Cr₹45 Cr24.2%
Q1 FY26₹186 Cr₹40 Cr21.8%
Q4 FY25₹167 Cr₹27 Cr16.0%

Consolidated figures (₹ crore, XBRL filings).

Shareholding and Delivery

Promoters held 43.56% of Advanced Enzyme Technologies Ltd's shares as of Sept 2026, against 43.07% in Sept 2025 (+0.49 percentage points). Delivery averaged 55.7% of traded volume across 16 NSE sessions (22 Oct 2026 – 13 Nov 2026).

About Advanced Enzyme Technologies Ltd

Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing and malting, starch and grain processing, protein modification, yeast processing, dairy and cheese processing, and oils and fats processing, as well as for specialty applications, biofuels, and bio-catalysis. It also provides non-food processing enzymes for textile, leather, and pulp and paper processing, as well as detergents and cleaning aids. The company was formerly known as Advanced Biochemicals Limited and changed its name to Advanced Enzyme Technologies Limited in 2005. Advanced Enzyme Technologies Limited was founded in 1957 and is headquartered in Thane, India.

Products and Services

1. Manufacturing and Sales of Enzymes-This segment researches and develops, manufactures, and markets enzymes and probiotics.

Business Segments

1. Manufacturing and Sales of Enzymes-100%

Frequently Asked Questions

What is the current share price of Advanced Enzyme Technologies Ltd?

Advanced Enzyme Technologies Ltd is trading at ₹284.60, with a market capitalisation of ₹3,151 Cr.

Which sector does Advanced Enzyme Technologies Ltd belong to?

Advanced Enzyme Technologies Ltd operates in the Materials > Chemicals > Speciality Chemicals space (Specialty Chemicals > Enzymes and Industrial Biotechnology).

What are the key financial ratios of Advanced Enzyme Technologies Ltd?

Advanced Enzyme Technologies Ltd has a P/E of 18.9 and a return on equity of 11.02%.

What is the stock symbol of Advanced Enzyme Technologies Ltd?

Advanced Enzyme Technologies Ltd is listed on the NSE under the symbol ADVENZYMES and on the BSE under the scrip code 540025.

How has Advanced Enzyme Technologies Ltd's share price moved over the past year?

Advanced Enzyme Technologies Ltd's share price is down 8.6% over one year and down 5.7% over three months. Its 52-week range is ₹246.80 to ₹419.00.

What were Advanced Enzyme Technologies Ltd's latest quarterly results?

In Q2 FY27, Advanced Enzyme Technologies Ltd reported revenue of ₹215 Cr and net profit of ₹51 Cr, with basic EPS of ₹4.33 (consolidated, parsed from the company's exchange filing).

How have Advanced Enzyme Technologies Ltd's revenue and profit changed over the past year?

Advanced Enzyme Technologies Ltd reported revenue of ₹215 Cr in Q2 FY27, up 16.2% from ₹185 Cr in Q2 FY26 and up 13.0% from ₹190 Cr in Q1 FY27.

What is the promoter holding in Advanced Enzyme Technologies Ltd?

Promoters held 43.56% of Advanced Enzyme Technologies Ltd's shares as of Sept 2026, against 43.07% in Sept 2025 (+0.49 percentage points).

More on FinBizNet

Data as of 16 Nov 2026. Descriptive market data only — not investment advice.